Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × enzalutamide × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 22 Prostatic Neoplasms, Castration-Resistant 4 Recurrence 2 Neoplasm Metastasis 2 Metastatic Castration-Resistant Prostate Cancer 2 mCRPC 1 Small Cell Lung Carcinoma 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Primary Dysautonomias 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm, Residual 1 Metastatic Hormone-sensitive Prostate Cancer 1 Lymphoma, Follicular 1 Kidney Diseases 1 Hypertension 1 Dementia 1 Cognitive Dysfunction 1 Breast Neoplasms 1 Bites and Stings 1 Biochemically Recurrent Prostate Cancer 1

Interventions

Rituximab 19 Cyclophosphamide 19 Prednisone 13 Lenalidomide 11 Doxorubicin 11 Oxaliplatin 9 Gemcitabine 9 fludarabine 8 Specimen Handling 8 Vincristine 7 Magnetic Resonance Spectroscopy 7 polatuzumab vedotin 6 Etoposide 6 glofitamab 5 CT-P10 5 venetoclax 4 obinutuzumab 4 ibrutinib 4 fludarabine phosphate 4 axicabtagene ciloleucel 4 Biopsy 4 deltacortene 3 Prednisolone 3 Leukapheresis 3 Ifosfamide 3 prednylidene 2 pembrolizumab 2 acalabrutinib 2 Whole-Body Irradiation 2 Spinal Puncture 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡